2016
DOI: 10.1093/toxsci/kfw064
|View full text |Cite
|
Sign up to set email alerts
|

Arsenite and Cadmium Activate MAPK/ERK via Membrane Estrogen Receptors and G-Protein Coupled Estrogen Receptor Signaling in Human Lung Adenocarcinoma Cells

Abstract: Epidemiological evidence indicates that cadmium and arsenic exposure increase lung cancer risk. Cadmium and arsenic are environmental contaminants that act as endocrine disruptors (EDs) by activating estrogen receptors (ERs) in breast and other cancer cell lines but their activity as EDs in lung cancer is untested. Here, we examined the effect of cadmium chloride (CdCl2) and sodium arsenite (NaAsO2) on the proliferation of human lung adenocarcinoma cell lines. Results demonstrated that both CdCl2 and NaAsO2 st… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
33
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(39 citation statements)
references
References 68 publications
6
33
0
Order By: Relevance
“…For instance, Huang et al found one of chemokines, TGF-β1, could ameliorate Cd-induced nephrotoxicity [40]. Meanwhile, Huff et al showed that arsenate and Cd could activate G-protein coupled estrogen receptor signaling in human lung adenocarcinoma cells [41]. Our results are consistent with these findings.…”
Section: Discussionsupporting
confidence: 89%
“…For instance, Huang et al found one of chemokines, TGF-β1, could ameliorate Cd-induced nephrotoxicity [40]. Meanwhile, Huff et al showed that arsenate and Cd could activate G-protein coupled estrogen receptor signaling in human lung adenocarcinoma cells [41]. Our results are consistent with these findings.…”
Section: Discussionsupporting
confidence: 89%
“…Moreover, a clinical investigation revealed that postmenopausal women who received estrogen plus progestin treatment exhibit an increased number of deaths from lung cancer [ 42 ]. The estrogen signaling pathway was also involved in cellular cytoskeleton organization [ 43 ] and cross-talk with the MAPK signaling pathway [ 44 ]. Taken together, biological function analyses of these six miRNAs strongly suggest critical roles in LUAD, which may provide a new strategy for LUAD diagnosis and prognosis.…”
Section: Discussionmentioning
confidence: 99%
“…Many studies have shown that ERβ is significantly higher in NSCLC tissues and was associated with poor prognosis in NSCLC patients . Overexpression of ERβ is associated with the expression of p‐44/42 MAPK in lung cancer, which can promote cell proliferation and invasion and inhibit cell apoptosis in lung cancer cells . It has been reported that ERβ and IL‐6 can promote the progression of NSCLC by activating the two signaling pathways of JAK2/STAT3 and MEK/ERK, but which ERβ subtype plays a role in NSCLC remains unclear.…”
Section: Discussionmentioning
confidence: 99%